Immune checkpoint inhibitors: A new opportunity in the treatment of ovarian cancer?

Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4); Immune checkpoint inhibitor; Ipilimumab; Nivolumab; Ovarian cancer; Pembrolizumab; Programmed cell death ligand-1 (PD-L1); Programmed cell death-1 (PD-1); Tumor infiltrating lymphocytes (TILs); Physical and Theoretical Chemistry; Organic Chemistry; Spectroscopy; Inorganic Chemistry; Catalysis; Molecular Biology; Computer Science Applications1707 Computer Vision and Pattern Recognition